Effects of Prostate-Rectum Separation on Rectal Dose From External Beam Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1251-1258

  Susil, Robert C ^a   McNutt, Todd R ^a   DeWeese, Theodore L ^a   Song, Danny ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

external beam radiotherapy; Prostate cancer; rectum; side effects

Indexed keywords

BEFORE AND AFTER; CLINICAL STUDY; DELIVERY TECHNIQUES; DOSE REDUCTION; DOSE TOLERANCE; EXTERNAL BEAM RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; PLANNING TARGET VOLUMES; PROSTATE CANCERS; RADIATION DOSE; RECTAL TOXICITY; SEMINAL VESICLE; SIDE EFFECT; SIMULATION STUDIES;

DOSIMETRY; HYDROGELS; SEPARATION;

RADIOTHERAPY;

ARTICLE; CADAVER; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYDROGEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE; RECTUM; SEMINAL VESICLE;

CADAVER; HUMANS; HYDROGEL; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 77449103010     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1679     Document Type: Article

References (23)

1. Al-Mamgani A., Heemsbergen W.D., Peeters S.T., et al. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 73 (2009) 685-691
2. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129
3. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
4. Burman C., Chui C.S., Kutcher G., et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39 (1997) 863-873
5. Lindsey I., Guy R.J., Warren B.F., et al. Anatomy of Denonvilliers fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 87 (2000) 1288-1299
6. Villers A., McNeal J.E., Freiha F.S., et al. Invasion of Denonvilliers fascia in radical prostatectomy specimens. J Urol 149 (1993) 793-798
7. Onik G. Image-guided prostate cryosurgery: State of the art. Cancer Control 8 (2001) 522-531
8. Saliken J.C., Donnelly B.J., and Rewcastle J.C. The evolution and state of modern technology for prostate cryosurgery. Urology 60 (2002) 26-33
9. Noyes WR, Noyes WR. Fillers and methods for displacing tissues to improve radiological outcomes. U.S. Patent 2004/0094162 A1.
10. Prada P.J., Gonzalez H., Menendez C., et al. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients. Brachytherapy 8 (2009) 210-217
11. Prada P.J., Fernandez J., Martinez A.A., et al. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys 69 (2007) 95-102
12. BioProtect: Evaluation of the safety and efficacy of the BioProtect balloon in prostate cancer subjects undergoing radiotherapy: NCT00462124. Available at: www.clinicaltrials.gov 2008. Accessed August 18, 2009.
13. Confluent Surgical Inc. DuraSeal Dural Sealant System Instructions for Use (2007), Confluent Surgical, Inc., Waltham, MA
14. Food and Drug Administration. DuraSeal Dural Sealant System: Summary of Safety and Effectiveness Data, 11/30/2004. Available at: www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078645.htm. Accessed August 18, 2009.
15. Bailey C.M., and Gilbert J.M. Avoiding inappropriate surgery for secondary rectal cancer. Eur J Surg Oncol 28 (2002) 220-224
16. Bowrey D.J., Otter M.I., and Billings P.J. Rectal infiltration by prostatic adenocarcinoma: Report on six patients and review of the literature. Ann R Coll Surg Engl 85 (2003) 382-385
17. Murray S.K., Breau R.H., Guha A.K., et al. Spread of prostate carcinoma to the perirectal lymph node basin: Analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol 28 (2004) 1154-1162
18. Lane Z., Epstein J.I., Ayub S., et al. Prostatic adenocarcinoma in colorectal biopsy: Clinical and pathologic features. Hum Pathol 39 (2008) 543-549
19. 2008 Drug Topics Red Book (2008), Blackwell, Montvale, NJ
20. Gorton E., Stanton S., Monga A., et al. Periurethral collagen injection: A long-term follow-up study. BJU Int 84 (1999) 966-971
21. Edwards P.C., Fantasia J.E., and Iovino R. Foreign body reaction to hyaluronic acid (Restylane): An adverse outcome of lip augmentation. J Oral Maxillofac Surg 64 (2006) 1296-1299
22. Pinheiro M.V., Bagatin E., Hassun K.M., et al. Adverse effect of soft tissue augmentation with hyaluronic acid. J Cosmet Dermatol 4 (2005) 184-186
23. Ghislanzoni M., Bianchi F., Barbareschi M., et al. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol 154 (2006) 755-758